In vivo interaction assays demonstrated that PCa-associated SPOP mutants lost their interaction with PIAS1 under olaparib treatment and exhibited a dominant negative effect on SPOP-WT (Figure 5B). The gene discussed is SPOP; the disease is posterior cortical atrophy.